{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:31:10Z","timestamp":1751898670464,"version":"3.40.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,29]]},"DOI":"10.7759\/cureus.81404","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T08:07:49Z","timestamp":1743235669000},"source":"Crossref","is-referenced-by-count":1,"title":["Cilnidipine: An L- and N-Type Blocker of Calcium Channels Ameliorating Renal Damage in Experimental Hypertensive Rats"],"prefix":"10.7759","author":[{"given":"Gouher","family":"Banu Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusal K","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.29.933","article-title":"Effects of L\/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats","volume":"29","author":"Konda T","year":"2006","unstructured":"Konda T, Enomoto A, Takahara A, Yamamoto H. Effects of L\/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats. Biol Pharm Bull. 2006, 29:933-7. 10.1248\/bpb.29.933","journal-title":"Biol Pharm Bull"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp604","article-title":"Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats","volume":"25","author":"Bae EH","year":"2010","unstructured":"Bae EH, Kim IJ, Park JW, Ma SK, Lee JU, Kim SW. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats. Nephrol Dial Transplant. 2010, 25:1051-9. 10.1093\/ndt\/gfp604","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.279","article-title":"L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats","volume":"34","author":"Toba H","year":"2011","unstructured":"Toba H, Yoshida M, Tojo C, et al.. L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Hypertens Res. 2011, 34:521-9. 10.1038\/hr.2010.279","journal-title":"Hypertens Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.49.723","article-title":"Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles","volume":"49","author":"Konno Y","year":"2008","unstructured":"Konno Y, Kimura K. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles. Int Heart J. 2008, 49:723-32. 10.1536\/ihj.49.723","journal-title":"Int Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0b013e328336ade3","article-title":"Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte","volume":"28","author":"Fan YY","year":"2010","unstructured":"Fan YY, Kohno M, Nakano D, et al.. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens. 2010, 28:1034-43. 10.1097\/hjh.0b013e328336ade3","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37774","article-title":"Blood pressure reducing potential and renoprotective action of cilnidipine among hypertensive patients suffering from chronic kidney disease: a meta-analysis","volume":"15","author":"Kumari K","year":"2023","unstructured":"Kumari K, Sinha R, Toppo MS, Mishra P, Alam S, Majhee L. Blood pressure reducing potential and renoprotective action of cilnidipine among hypertensive patients suffering from chronic kidney disease: a meta-analysis. Cureus. 2023, 15:e37774. 10.7759\/cureus.37774","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322011000800025","article-title":"Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats","volume":"66","author":"Girardi JM","year":"2011","unstructured":"Girardi JM, Farias RE, Ferreira AP, Raposo NR. Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats. Clinics (Sao Paulo). 2011, 66:1457-62. 10.1590\/s1807-59322011000800025","journal-title":"Clinics (Sao Paulo)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00047.2010","article-title":"High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity","volume":"299","author":"Kopkan L","year":"2010","unstructured":"Kopkan L, Hess A, Huskov\u00e1 Z, Cervenka L, Navar LG, Majid DS. High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Renal Physiol. 2010, 299:F656-63. 10.1152\/ajprenal.00047.2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21315\/mjms2017.24.5.11","article-title":"Sample size calculations animal studies using the resource equation approach","volume":"24","author":"Arifin WN","year":"2017","unstructured":"Arifin WN, Zahiruddin WM. Sample size calculations animal studies using the resource equation approach. Malays J Med Sci. 2017, 24:101-5. 10.21315\/mjms2017.24.5.11","journal-title":"Malays J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair AB","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016, 7:27-31. 10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpae066","article-title":"Augmentation of nitric oxide deficient hypertension by high salt diet is associated with reduced TNF-\u03b1 receptor type 1 expression in the kidneys","volume":"37","author":"Majid DS","year":"2024","unstructured":"Majid DS, Prieto MC, Castillo A, Chamberlain C, Navar LG. Augmentation of nitric oxide deficient hypertension by high salt diet is associated with reduced TNF-\u03b1 receptor type 1 expression in the kidneys. Am J Hypertens. 2024, 37:717-25. 10.1093\/ajh\/hpae066","journal-title":"Am J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2013.17.4.339","article-title":"Effect of lutein on L-NAME-induced hypertensive rats","volume":"17","author":"Sung JH","year":"2013","unstructured":"Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, Ko HJ, Sim SS. Effect of lutein on L-NAME-induced hypertensive rats. Korean J Physiol Pharmacol. 2013, 17:339-45. 10.4196\/kjpp.2013.17.4.339","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12360","article-title":"Comparison of the cardioprotective and renoprotective effects of the L\/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats","volume":"42","author":"Aritomi S","year":"2015","unstructured":"Aritomi S, Harada E, Sugino K, Nishimura M, Nakamura T, Takahara A. Comparison of the cardioprotective and renoprotective effects of the L\/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats. Clin Exp Pharmacol Physiol. 2015, 42:344-52. 10.1111\/1440-1681.12360","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/133.1.180","article-title":"Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats","volume":"133","author":"Lu J","year":"2003","unstructured":"Lu J, Bankovic-Calic N, Ogborn M, Saboorian MH, Aukema HM. Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats. J Nutr. 2003, 133:180-6. 10.1093\/jn\/133.1.180","journal-title":"J Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01521-7","article-title":"Antisympathetic and hemodynamic property of a dual L\/N-type Ca (2+) channel blocker cilnidipine in rats","volume":"434","author":"Takahara A","year":"2002","unstructured":"Takahara A, Koganei H, Takeda T, Iwata S. Antisympathetic and hemodynamic property of a dual L\/N-type Ca (2+) channel blocker cilnidipine in rats. Eur J Pharmacol. 2002, 434:43-7. 10.1016\/S0014-2999(01)01521-7","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2009.00126.x","article-title":"Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus","volume":"29","author":"Masuda T","year":"2011","unstructured":"Masuda T, Ogura MN, Moriya T, et al.. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus. Cardiovasc Ther. 2011, 29:46-53. 10.1111\/j.1755-5922.2009.00126.x","journal-title":"Cardiovasc Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282c2fa62","article-title":"Renal and vascular protective effects of cilnidipine in patients with essential hypertension","volume":"25","author":"Morimoto S","year":"2007","unstructured":"Morimoto S, Yano Y, Maki K, Iwasaka T. Renal and vascular protective effects of cilnidipine in patients with essential hypertension. J Hypertens. 2007, 25:2178-83. 10.1097\/HJH.0b013e3282c2fa62","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27847","article-title":"Renal function in hypertensive patients receiving cilnidipine and l-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies","volume":"14","author":"Srivathsan M","year":"2022","unstructured":"Srivathsan M, Vardhan V, Naseem A, Patil S, Rai V, Langade DG. Renal function in hypertensive patients receiving cilnidipine and l-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies. Cureus. 2022, 14:e27847. 10.7759\/cureus.27847","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.09.056","article-title":"Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels","volume":"106","author":"Tanaka M","year":"2014","unstructured":"Tanaka M, Sekioka R, Nishimura T, Ichihara A, Itoh H. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels. Diabetes Res Clin Pract. 2014, 106:504-10. 10.1016\/j.diabres.2014.09.056","journal-title":"Diabetes Res Clin Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Ba\u015f M","year":"2015","unstructured":"Ba\u015f M, Greve J, Stelter K, et al.. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015, 372:418-25. 10.1056\/NEJMoa1312524","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-018-0761-y","article-title":"Chrysin pretreatment improves angiotensin system, cGMP concentration in L-NAME induced hypertensive rats","volume":"34","author":"Veerappan R","year":"2019","unstructured":"Veerappan R, Malarvili T. Chrysin pretreatment improves angiotensin system, cGMP concentration in L-NAME induced hypertensive rats. Indian J Clin Biochem. 2019, 34:288-95. 10.1007\/s12291-018-0761-y","journal-title":"Indian J Clin Biochem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.187","article-title":"Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats","volume":"36","author":"Takai S","year":"2013","unstructured":"Takai S, Jin D, Aritomi S, Niinuma K, Miyazaki M. Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats. Hypertens Res. 2013, 36:342-8. 10.1038\/hr.2012.187","journal-title":"Hypertens Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.095","article-title":"The renin-angiotensin system in hypertension, a constantly renewing classic: focus on the angiotensin AT(2)-receptor","volume":"36","author":"Assersen KB","year":"2020","unstructured":"Assersen KB, Sumners C, Steckelings UM. The renin-angiotensin system in hypertension, a constantly renewing classic: focus on the angiotensin AT(2)-receptor. Can J Cardiol. 2020, 36:683-93. 10.1016\/j.cjca.2020.02.095","journal-title":"Can J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.191","article-title":"Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis","volume":"34","author":"Aritomi S","year":"2011","unstructured":"Aritomi S, Wagatsuma H, Numata T, et al.. Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis. Hypertens Res. 2011, 34:193-201. 10.1038\/hr.2010.191","journal-title":"Hypertens Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2018.8.0723228072018","article-title":"A randomized open-label study to compare the effects of amlodipine and cilnidipine on heart rate and proteinuria in subjects with hypertension with proteinuria","volume":"8","author":"Shanbhag AD","year":"2018","unstructured":"Shanbhag AD, Gowda HN, Laxmegowda. A randomized open-label study to compare the effects of amlodipine and cilnidipine on heart rate and proteinuria in subjects with hypertension with proteinuria. Natl J Physiol Pharm Pharmacol. 2018, 8:1485-90. 10.5455\/njppp.2018.8.0723228072018","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref26","article-title":"To evaluate effect of olmesartan versus cilnidipine on urinary microalbumin level in patients of hypertension with type II diabetes mellitus","volume":"4","author":"Anand","year":"2021","unstructured":"Anand, Bajpai A, Aboobecker SP. To evaluate effect of olmesartan versus cilnidipine on urinary microalbumin level in patients of hypertension with type II diabetes mellitus. Int J Health Clin Res. 2021, 4:18-21.","journal-title":"Int J Health Clin Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.12075fp","article-title":"N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition","volume":"119","author":"Lei B","year":"2012","unstructured":"Lei B, Nakano D, Fujisawa Y, et al.. N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition. J Pharmacol Sci. 2012, 119:359-67. 10.1254\/jphs.12075fp","journal-title":"J Pharmacol Sci"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.4103\/2231-4040.154543","article-title":"Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study","volume":"6","author":"Adake P","year":"2015","unstructured":"Adake P, Somashekar HS, Mohammed Rafeeq PK, Umar D, Basheer B, Baroudi K. Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study. J Adv Pharm Technol Res. 2015, 6:81-5.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.96","article-title":"Renoprotective and antioxidant effects of cilnidipine in hypertensive patients","volume":"35","author":"Soeki T","year":"2012","unstructured":"Soeki T, Kitani M, Kusunose K, et al.. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients. Hypertens Res. 2012, 35:1058-62. 10.1038\/hr.2012.96","journal-title":"Hypertens Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307937-cilnidipine-an-l--and-n-type-blocker-of-calcium-channels-ameliorating-renal-damage-in-experimental-hypertensive-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T08:07:52Z","timestamp":1743235672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307937-cilnidipine-an-l--and-n-type-blocker-of-calcium-channels-ameliorating-renal-damage-in-experimental-hypertensive-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.81404","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}